GENE ONLINE|News &
Opinion
Blog

mRNA
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
An Interview with AusBiotech CEO Lorraine Chiroiu, Highlighting Innovations and Growth in the Australian Biotech Sector
2023-12-16
Breakthrough Stem Cell Treatment Shows Promise in Reversing Liver Disease
2023-12-08
GeneOnline’s Weekly News Highlights: Oct 30-Nov 3
2023-11-07
Moderna Launches mRNA Platform Incubator Network to Boost Australian mRNA Research
2023-11-06
Victoria Offers Grants to Accelerate mRNA-Based Therapeutics Research
2023-11-01
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
The World’s First mRNA Vaccine to Fight Against Antibiotic-Resistant Bacteria
2023-03-14
A New Phase in Drug Development: Programming the Genome
2023-03-02
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
2022-04-27
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
Was Novavax’s Vaccine Rollout Smooth?
2022-03-16
1 2 3
LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top